MedMira Secures Authorization for Syphilis Test Trials

MedMira Inc. has received investigational testing authorization from Health Canada for clinical trials of its Multiplo® Complete Syphilis (TP/nTP) Antibody Test. This device detects both active and non-active syphilis, addressing a pressing health need.

The trials, funded by the Canadian Institute of Health Research and Indigenous Services Canada, will be conducted by REACH Nexus at St. Michael's Hospital. The Multiplo® TP/nTP test promotes a faster, more accurate method for syphilis detection.

With a significant increase in syphilis cases in Canada, this test aims to improve access to diagnosis in underserved regions. This collaboration between private and public sectors seeks to address health inequities and provide efficient healthcare solutions.